Nipro North America has launched the Cronus HP high-pressure, 0.035" over-the-wire (OTW) percutaneous transluminal angioplasty (PTA) balloon catheter in the US.
The Cronus HP has been developed to carry out percutaneous transluminal angioplasty in the femoral, popliteal, iliac and renal arteries.
It will also be used to treat obstructive lesions in native or synthetic arteriovenous dialysis fistulae.
The device can be used for the treatment of AVF stenoses ranging from simple, focal, venous outflow strictures to more complex juxta-anastomotic obstructions in early fistula failures.
The company said the semi-compliant balloon offers enhanced flexibility at high pressure, as well as minimizes balloon elongation and dog bone effect.
Nipro interventional division national sales manager John O’Connor said: "Cronus HP provides physicians with a high-pressure PTA balloon catheter, specifically designed to successfully balloon the most resilient stenoses that are typically resistant to expansion, while being flexible enough to conform to natural vasculature of native fistulae."
"This is particularly important at and across the anastomosis, where less vessel straightening leads to minimal vascular damage and superior outcomes."
The device features laser bonding at critical flex points and low profiles along its catheter shaft, which helps in achieving better trackability and pushability when compared to guidewires.
The device’s pleat technology enables for crossability in highly stenosed lesions and improved re-cross when several inflations are needed in resilient stenoses.
The device is being made available in different lengths and diameters to treat focal and AVF stenoses.